Exicure, Inc.
Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use

Last updated:

Abstract:

Aspects of the invention relate to spherical nucleic acid-based constructs and related methods and compositions thereof. The compositions of the invention are useful for activating agonists of nucleic acid interacting complexes, such as TLRs, stimulating an immune response, and treating diseases such as infectious disease, cancer, allergies, allergic diseases, and autoimmune disease

Status:
Grant
Type:

Utility

Filling date:

25 Jul 2014

Issue date:

19 Jan 2021